Single-Use Bioreactors Market to Reach $13.6 Billion by 2030 Fueled by Biologic Drug Demand

The single-use bioreactors market, valued at USD 4.1 billion in 2024, is projected to reach USD 13.6 billion by 2030, growing at a compound annual rate of 22.0%. This surge is driven by the increasing demand for biologic and biosimilar drugs due to the rising prevalence of communicable and chronic diseases, coupled with the availability of innovative single-use bioreactors.

In 2022, the system category dominated the market with a 55% share, primarily due to its extensive use in biopharmaceutical manufacturing facilities that require high product yields. These systems are favored for their cost-effectiveness, adaptability, and significant production capabilities.

The market is also propelled by the growing demand for rapid expansion in biotherapeutics, including hormones, vaccines, antibodies, and enzymes, which can be efficiently produced using these bioreactors. Consequently, these factors are contributing to the market's growth in this segment.

Within the type segment, stirred-tank bioreactors held the largest market share at 45%, owing to their numerous benefits such as low operating costs, efficient fluid mixing, and oxygen transfer capabilities, as well as easy scalability. Meanwhile, the wave-induced category is expected to experience substantial growth in the future, attributed to advancements in manufacturing and benefits like flexible accessory configurations, easy handling, cost efficiency, and longevity.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=single-use-bioreactors-market

In terms of cell type, mammalian cells led the market, as they are widely used in the development of recombinant proteins and biopharmaceutical therapies. Studies indicate that a significant number of biopharma candidates are developed using mammalian cell cultures. Yeast cells are anticipated to see significant growth in the future due to their advantages in therapeutic recombinant production and their role as hosts for biopharma synthesis.

North America is the leading region in the single-use bioreactors market, driven by the increasing prevalence of chronic diseases such as diabetes, the presence of key industry players, advanced healthcare facilities, technological advancements, and strong R&D initiatives supported by ample research funding. The U.S. is a key contributor to this market growth, thanks to the adoption of innovative technologies, rising public awareness of disease prevention, strong government support, and state-of-the-art healthcare infrastructure.

The global demand for single-use bioreactors is rising due to the growing number of collaborations among companies worldwide.

About P&S Intelligence

 

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

 

Contact:
Chandra Mohan
AVP – Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com